Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary

Basu, N; Brogan, P; D'Cruz, D; Dhaun, N; Flossmann, O; Harper, L; Jayne, DRW; Jones, RB; Lanyon, PC; Luqmani, RA; McAdoo, SP; Mukhtyar, C; Pearce, FA; Pusey, CD; Robson, JC; Salama, AD; Smith, R; Smyth, L; Tieu, J; Watts, RA; Willcocks, LC

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary

Authors: N Basu
P Brogan
D D'Cruz
N Dhaun
O Flossmann
L Harper
DRW Jayne
RB Jones
PC Lanyon
RA Luqmani
SP McAdoo
C Mukhtyar
FA Pearce
CD Pusey
JC Robson
AD Salama
R Smith
L Smyth
J Tieu
RA Watts
LC Willcocks
Publication date: 1 April 2020
Publisher: OXFORD UNIV PRESS

Abstract

[This is the executive summary of Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines: full guideline, doi: 10.1093/rheumatology/kez640

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

UCL Discovery

oai:eprints.ucl.ac.uk.OAI2:101...

Last time updated on 10/07/2020